1,679
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Immune responses induced by diclofenac or carbamazepine in an oral exposure model using TNP-Ficoll as reporter antigen

, , , , , , & show all
Pages 918-926 | Received 06 Jul 2016, Accepted 10 Oct 2016, Published online: 14 Dec 2016

References

  • Aithal G, Ramsay L, Daly A, Sonchit N, Leathart J, Alexander G, Kenna J, Caldwell J, Day C. 2004. Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity. Hepatology. 39:1430–1440.
  • Albers R, Broeders A, van der Pijl A, Seinen W, Pieters R. 1997. The use of reporter antigens in the popliteal lymph node assay to assess immunomodulation by chemicals. Toxicol Appl Pharmacol. 143:102–109.
  • Boelsterli U. 2003. Diclofenac-induced liver injury: A paradigm of idiosyncratic drug toxicity. Toxicol Appl Pharmacol. 192:307–322.
  • Bol-Schoenmakers M, Bleumink R, Rezende MM, Mouser E, Hassing I, Ludwig I, Smit JJ, Pieters RH. 2011. Diclofenac enhances allergic responses in a mouse peanut allergy model. Clin Exp Allergy. 41:424–433.
  • Chalasani N, Björnsson E. 2010. Risk factors for idiosyncratic drug-induced liver injury. Gastroenterology. 138:2246–2259.
  • Gocinski B, Tigelaar R. 1990. Roles of CD4+ and CD8+ T-cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. J Immunol. 144:4121–4128.
  • Gomes E, Demoly P. 2005. Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol. 5:309–316.
  • Griem P, Wulferink M, Sachs B, Gonzalez J, Gleichmann E. 1998. Allergic and autoimmune reactions to xenobiotics: How do they arise? Immunol Today. 19:133–141.
  • Gutting B, Schomaker S, Kaplan A, Amacher D. 1999. A comparison of the direct and reporter antigen popliteal lymph node assay for the detection of immunomodulation by low molecular weight compounds. Toxicol Sci. 51:71–79.
  • Gutting B, Updyke L, Amacher D. 2002a. BALB/c mice orally pretreated with diclofenac have augmented and accelerated PLNA responses to diclofenac. Toxicology. 172:217–230.
  • Gutting B, Updyke L, Amacher D. 2002b. Diclofenac activates T-cells in direct popliteal lymph node assay and selectively induces IgG(1) and IgE against co-injected TNP-OVA. Toxicol Lett. 131:167–180.
  • Ju C, Uetrecht J. 1999. Detection of 2-hydroxyiminostilbene in the urine of patients taking carbamazepine and its oxidation to a reactive iminoquinone intermediate. J Pharmacol Exp Ther. 288:51–56.
  • Kammüller M, Thomas C, De Bakker J, Bloksma N, Seinen W. 1989. The popliteal lymph node assay in mice to screen for the immune disregulating potential of chemicals – a preliminary study. Int J Immunopharmacol. 11:293–300.
  • Kang P, Liao M, Wester M, Leeder J, Pearce R, Correia M. 2008. CYP3A4-mediated carbama-zepine (CBZ) metabolism: Formation of a covalent CBZ-CYP3A4 adduct and alteration of the enzyme kinetic profile. Drug Metab Dispos. 36:490–499.
  • Kwast L, Fiechter D, Kruijssen L, Bleumink R, Ludwig I, Bol-Schoenmakers M, Smit J, Pieters R. 2016. Oral exposure to immunostimulating drugs results in early changes in innate immune parameters in the spleen. J Immunotoxicol. 15:1–13.
  • Kwast L, Fiechter D, Hassing I, Bleumink R, Boon L, Ludwig I, Pieters R. 2011. Oral exposure to drugs with immune-adjuvant potential induces hypersensitivity responses to the reporter antigen TNP-OVA. Toxicol Sci. 121:312–319.
  • Lee W. 2003. Drug-induced hepatotoxicity. N Engl J Med. 349:474–485.
  • Lertratanangkoon K, Horning M. 1982. Metabolism of carbamazepine. Drug Metab Dispos. 10:1–10.
  • Lillibridge J, Amore B, Slattery J, Kalhorn T, Nelson S, Finnell R, Bennett G. 1996. Protein-reactive metabolites of carbamazepine in mouse liver microsomes. Drug Metab Dispos. 24:509–514.
  • Martin S, Lappin M, Kohler J, Delattre V, Leicht C, Preckel T, Simon J, Weltzien H. 2000. Peptide immunization indicates that CD8+ T-cells are dominant effector cells in trinitrophenyl-specific contact hypersensitivity. J Investig Dermatol 115:260–266.
  • Mauri-Hellweg D, Bettens F, Mauri D, Brander C, Hunziker T, Pichler W. 1995. Activation of drug-specific CD4+ and CD8+ T-cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. J Immunol. 155:462–472.
  • Naisbitt D, Britschgi M, Wong G, Farrell J, Depta J, Chadwick D, Pichler W, Pirmohamed M, Park B. 2003. Hypersensitivity reactions to carbamazepine: Characterization of the specificity, phenotype, and cytokine profile of drug-specific T-cell clones. Mol Pharmacol 63:732–741.
  • Naisbitt D, Sanderson L, Meng X, Stachulski A, Clarke S, Park B. 2007. Investigation of the immunogenicity of diclofenac and diclofenac metabolites. Toxicol Lett. 168:45–50.
  • Nierkens S, Aalbers M, Bol M, van Wijk F, Hassing I, Pieters R. 2005. Development of an oral exposure mouse model to predict drug-induced hypersensitivity reactions by using reporter antigens. Toxicol Sci. 83:273–281.
  • Njoku D. 2010. Suppressive and pro-inflammatory roles for IL-4 in the pathogenesis of experimental drug-induced liver injury: A review. Expert Opin Drug Metab Toxicol. 6:519–531.
  • Pichler W, Naisbitt D, Park B. 2011. Immune pathomechanism of drug hypersensitivity reactions. J Allergy Clin Immunol. 127: S74–S81.
  • Pieters R. 2001. The popliteal lymph node assay: A tool for predicting drug allergies. Toxicology 158:65–69.
  • Pieters R, Albers R. 1999a. Screening tests for autoimmune-related immunotoxicity. Environ Health Perspect. 107S:673–677.
  • Pieters R, Albers R. 1999b. Assessment of autoimmunogenic potential of xenobiotics using the popliteal lymph node assay. Methods. 19:71–77.
  • Pieters R, Ezendam J, Bleumink R, Bol M, Nierkens S. 2002. Predictive testing for autoimmunity. Toxicol Lett. 127:83–91.
  • Reuter B, Davies N, Wallace J. 1997. Nonsteroidal anti-inflammatory drug enteropathy in rats: Role of permeability, bacteria, and enterohepatic circulation. Gastroenterology. 112:109–117.
  • Roychowdhury S, Svensson C. 2005. Mechanisms of drug-induced delayed-type hypersensitivity reactions in the skin. AAPS J. 7:E834–E846.
  • Switzar L, Kwast L, Lingeman H, Giera M, Pieters R, Niessen W. 2013. Identification and quantification of drug-albumin adducts in serum samples from a drug exposure study in mice. J Chromatogr B Analyt Technol Biomed Life Sci. 917–918:53–61.
  • Uetrecht J. 2007. Idiosyncratic drug reactions: Current understanding. Annu Rev Pharmacol Toxicol. 47:513–539.
  • Ulrich R. 2007. Idiosyncratic toxicity: A convergence of risk factors. Annu Rev Med.58:17–34.
  • Vocanson M, Hennino A, Cluzel-Tailhardat M, Saint-Mezard P, Benetiere J, Chavagnac C, Berard F, Kaiserlian D, Nicolas J. 2006. CD8+ T-cells are effector cells of contact dermatitis to common skin allergens in mice. J Investig Dermatol. 126:815–820.
  • Wade L, Kenna J, Caldwell J. 1997. Immunochemical identification of mouse hepatic protein adducts derived from the nonsteroidal anti-inflammatory drugs diclofenac, sulindac, and ibuprofen. Chem Res Toxicol. 10:546–555.
  • Ware J, Graf M, Martin B, Lustberg L, Pohl L. 1998. Immunochemical detection and identification of protein adducts of diclofenac in the small intestine of rats: Possible role in allergic reactions. Chem Res Toxicol. 11:164–171.
  • Zhang X, Liu F, Chen X, Zhu X, Uetrecht J. 2011. Involvement of the immune system in idiosyncratic drug reactions. Drug Metab Pharmacokinet. 26:47–59.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.